Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.93 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.93 |
| ▸ | ATM | Q13315 | 1/20 | 0.93 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.93 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | PRKCA | P17252 | 3/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL333145 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL4887025 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL153398 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL9986005 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL4625908 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL11412640 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL3225069 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL55305 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL9229154 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA | |
| SCHEMBL28217622 | 1.00 | TSHR (0.93) | TSHRCYP3A4ATMTDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1007 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4262687-A1 | COMPOSITION FOR CARING FOR THE SKIN | L'OREAL (FR) | 2023-10-25 | — | — | EP | claimed |
| CN-116847823-A | Composition for caring skin | 莱雅公司 | 2023-10-03 | — | — | CN | claimed |
| WO-2022126428-A1 | COMPOSITION FOR CARING FOR THE SKIN | L'OREAL (FR) | 2022-06-23 | — | — | WO | claimed |
| CN-107406539-B | Continuous gas phase polymerization process | 巴塞尔聚烯烃股份有限公司 | 2020-04-07 | — | — | CN | claimed |
| US-10358509-B2 | Continuous gas-phase polymerization processes | BASELL POLYOLEFINE GMBH (DE) | 2019-07-23 | — | — | US | claimed |
| US-20190183752-A1 | AGENT FOR CHANGING THE COLOR OF KERATIN-CONTAINING MATERIALS HAVING AT LEAST ONE ALCOHOL, A MODIFIED CLAY MINERAL AND A COLOR PIGMENT | HENKEL AG & CO. KGAA (DE) | 2019-06-20 | — | — | US | claimed |
| US-20190151216-A1 | COSMETIC COMPOSITIONS WITH REDUCED OILY OR GREASY FEEL ON THE SKIN | HENKEL AG & CO. KGAA (DE) | 2019-05-23 | — | — | US | claimed |
| EP-3397737-A2 | LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF | ExxonMobil Research and Engineering Company (US) | 2018-11-07 | — | — | EP | claimed |
| EP-3137516-B1 | CONTINUOUS GAS-PHASE POLYMERIZATION PROCESSES | BASELL POLYOLEFINE GMBH (DE) | 2018-04-25 | — | — | EP | claimed |
| US-20180079842-A1 | CONTINUOUS GAS-PHASE POLYMERIZATION PROCESSES | BASELL POLYOLEFINE GMBH (DE) | 2018-03-22 | — | — | US | claimed |
| EP-0995423-B1 | Cosmetic powder and its use as make-up remover or for skin and mucosa cleansing | OREAL (FR) | 2001-09-05 | — | — | EP | claimed |
| US-6242396-B1 | FATTY ESTER OIL; POLYALKYLENE ETHER CIMETHICONE COPOLYOL EMULSIFIER; MEDIUM IS FREE OF BRANCHED-CHAIN HYDROCARBON-BASED OIL. | L'OREAL (FR) | 2001-06-05 | — | — | US | claimed |
| US-5776596-A | LUBRICANTS | KAO CORPORATION (JP) | 1998-07-07 | — | — | US | claimed |
| EP-0817621-A1 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY | SANOFI (FR) | 1998-01-14 | — | — | EP | claimed |
| WO-1996030000-A1 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY | SANOFI (FR) | 1996-10-03 | — | — | WO | claimed |
| EP-0328158-B1 | A METHOD FOR IMPROVING THE RELEASE OF A CAST CONCRETE ITEM FROM THE MOULD BY APPLYING TO THE MOULD A MOULD RELEASE COMPOSITION | CASTROL A/S (DK) | 1993-06-30 | — | — | EP | claimed |
| EP-0180630-B1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | CASTROL A/S (DK) | 1991-10-09 | — | — | EP | claimed |
| EP-0328158-A1 | A method for improving the release of a cast concrete item from the mould by applying to the mould a mould release composition | CASTROL A/S (DK) | 1989-08-16 | — | — | EP | claimed |
| EP-0180630-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD. | KOEGE KEMISK VAERK (DK) | 1986-05-14 | — | — | EP | claimed |
| WO-1985005066-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | KEMISK VA^ERK KO^/GE A/S (DK) | 1985-11-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190183752-A1 | AGENT FOR CHANGING THE COLOR OF KERATIN-CONTAINING MATERIALS HAVING AT LEAST ONE ALCOHOL, A MODIFIED CLAY MINERAL AND A COLOR PIGMENT | KRT18, DOT1L, IK | TSHR 3175/4885CYP3A4 3630/4885ATM 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.